IMUC Update: ImmunoCellular Therapeutics Trading Higher On Very Heavy Volume

Trading volume for shares of Penny Stock ImmunoCellular Therapeutics (OTCBB: IMUC.OB) has been on the rise during the past few sessions. Shares are at 1.63 +0.08 (up 5.16%) as of 10:30am Today.

The biotechnology company focused on developing new therapeutics to fight cancer using the immune system saw 755,068 shares trade hands during the regular session—more than three times the daily average.

Shares closed Yesterday at 1.55 +0.20 (up 14.81%) when the closing bell rang, but headed higher after hours to close at $1.61 +0.06 (3.87%).

Although details are sketchy, speculators appear to be taking positions in the stock ahead of either pending developments or some kind of announcement. The only official word from the firm came earlier in the day when a news release informed investors that its president and CEO, Manish Singh Ph.D., was scheduled to present at the Immunotherapeutics Partnering and Deal Making Conference, currently taking place in San Diego, California.

Dr. Singh’s presentation titled “Targeting Cancer Stem Cells Via Immunotherapy” and was to include an overview of ImmunoCellular’s clinical activities to date including ICT-107, its lead program targeting cancer stem cells (CSC) in Glioblastoma. ICT-107 is currently in a randomized phase II clinical trial at multiple centers in the US. Company is also developing two additional products targeting CSCs in tumors via modulating immune system.

ICT107 is a new generation dendritic cell-based therapeutic vaccine that consists of a number of specific tumor antigens which, when loaded onto the dendritic cells, are expected to stimulate the body’s T cells to target only these specific proteins on the patient’s tumor cells. This is accomplished by extracting dendritic cells from a patient, loading them with the antigens, and reintroducing them to the patient’s body to trigger an immune response. ICT107 is being developed in the form of intradermal injection as a therapeutic vaccine for glioblastoma multiforme.

Watch IMUC closely for further developments and get it on your list of penny stocks to watch immediately.

Be fearful when others are greedy, and be greedy when others are fearful.” – Warren Buffett

If you really want to make some considerable profits from the stock market, it is possible to make a considerable amount of money on penny stock trading. When you find the right penny stock to buy, knowing when to buy and sell is the second most important tool to maximizing your profits.

Being technical, analytical or just flat-out greedy when trading penny stocks is the easiest way to limit profits and, sometimes, even lose your entire investment. You need to have a strong and strict strategy to achieve your goal of maximizing profits while minimizing risks in penny stocks.

Listed below are a few of the many points each and every penny stock investor needs to discover.

  • Do your own research.
  • Trade Responsibly.
  • Verify everything.
  • Move Fast or Get Left Behind.
  • Do not use market orders to enter a position, use limit orders.
  • Have a System That fits You.
  • If a Stock Gaps Open, Look for Pullbacks to Enter.
  • Plan a Trade and Trade a Plan.
  • Always use stop loss orders to protect yourself.
  • Positive Self- Belief.
  • Keep trading as Part of a Balanced life.
  • If a stock breaks below our alert price GET OUT. Do not wait.
  • View Trading as a Score in Points and Not In Money:
  • Always take your profits whenever you can. Do Not Be Greedy.
  • Work Hard at Learning How to Trade Properly and Keep Working.
  • Do something to make someone else’s life better today.

About strives to provide you with the hottest stock alerts in the market in Real-Time. We focus on stocks that trade for $5 per share or less, some as little as a few pennies with upside potential.

Our goal is committed to producing and publishing the highest-quality insight and analysis of small-cap stocks, emerging technology stocks, hot penny stocks and helping investors make informed decisions and to inform you of the best stocks in the market before they move. Our focus is primarily on OTC stocks in the stock market today which have traditionally been ignored by Wall Street.

We have particular expertise with internet stocks, gold stocks, renewable energy stocks, biotech stocks, oil stocks and green energy stocks. There are many hot penny stock opportunities present in the OTC market every day and we seek to exploit these hot stock gains for our members before the average daytrader is made aware of them.

Aim High Profits Disclaimer

This is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. is a wholly-owned subsidiary of Kelevra Media Innovation.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision.

Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

For a complete explanation, please visit our disclaimer page.

Last updated by at .

  Recent Penny Stock News